Patient attitudes and understanding about biosimilars: an international cross-sectional survey.

ABSTRACT:

Objective

To understand the levels of awareness, usage, and knowledge of biosimilars among patients, caregivers, and the general population in the US and the European Union; perceptions of biosimilars compared to originator biologics; perceived benefits and drawbacks of clinical trials; and whether advocacy groups impact patients' willingness to try a biosimilar.

Methods

An international survey was conducted which contained up to 56 closed-ended (requiring yes/no or ranking answers) and open-ended questions, depending on the population assigned. The survey was divided into distinct sections, including medication-class awareness, usage, and knowledge about biologic and biosimilar therapies; perceptions of clinical trials; and involvement in advocacy groups. Interviews were co

SUBMITTER: Jacobs I 

PROVIDER: S-EPMC4889091 | biostudies-literature | 2016

REPOSITORIES: biostudies-literature